Trupanion (NASDAQ:TRUP) Hits New 52-Week Low – Time to Sell?

Shares of Trupanion, Inc. (NASDAQ:TRUP) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $25.15 and last traded at $25.2340, with a volume of 169949 shares. The stock had previously closed at $26.47.

Analysts Set New Price Targets

Several equities analysts recently commented on TRUP shares. Piper Sandler dropped their price objective on Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Cantor Fitzgerald lowered their target price on Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Weiss Ratings cut Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Finally, Wall Street Zen lowered Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $45.50.

Trupanion Price Performance

The business’s 50 day moving average is $31.72 and its two-hundred day moving average is $37.64. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a market capitalization of $1.09 billion, a PE ratio of 55.87 and a beta of 1.62.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). The company had revenue of $376.85 million during the quarter, compared to the consensus estimate of $375.89 million. Trupanion had a return on equity of 5.39% and a net margin of 1.35%.Trupanion’s revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.04 earnings per share. Equities research analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Margaret Tooth sold 9,605 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $37.88, for a total value of $363,837.40. Following the sale, the chief executive officer directly owned 150,294 shares of the company’s stock, valued at approximately $5,693,136.72. This represents a 6.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 4,645 shares of the business’s stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $25.61, for a total transaction of $118,958.45. The SEC filing for this sale provides additional information. Insiders have sold 31,107 shares of company stock worth $949,347 in the last 90 days. 5.42% of the stock is owned by company insiders.

Institutional Trading of Trupanion

Several institutional investors and hedge funds have recently bought and sold shares of the company. Federated Hermes Inc. purchased a new position in shares of Trupanion during the 3rd quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Trupanion in the third quarter worth $39,000. Kelleher Financial Advisors bought a new stake in Trupanion during the third quarter valued at $74,000. Kemnay Advisory Services Inc. bought a new stake in Trupanion during the fourth quarter valued at $64,000. Finally, PNC Financial Services Group Inc. grew its position in Trupanion by 21.7% during the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after buying an additional 478 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.